Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Congenital intravascular abdominal aortic band initially thought to be a metallic foreign body: Characterization using microanatomical CT reconstruction technique.

Shelton CC, Tyagi SC, Sanampudi S, Issa MM, Raissi D, Lowry CM, Winkler MA.

Radiol Case Rep. 2019 Jul 15;14(9):1127-1131. doi: 10.1016/j.radcr.2019.06.031. eCollection 2019 Sep.


Once a frog-lover, always a frog-lover?: Infants' goal generalization is influenced by the nature of accompanying speech.

Martin A, Shelton CC, Sommerville JA.

J Exp Psychol Gen. 2017 Jun;146(6):859-871. doi: 10.1037/xge0000268. Epub 2017 Apr 20.


Activation and intrinsic gamma-secretase activity of presenilin 1.

Ahn K, Shelton CC, Tian Y, Zhang X, Gilchrist ML, Sisodia SS, Li YM.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21435-40. doi: 10.1073/pnas.1013246107. Epub 2010 Nov 29.


Modulation of gamma-secretase specificity using small molecule allosteric inhibitors.

Shelton CC, Zhu L, Chau D, Yang L, Wang R, Djaballah H, Zheng H, Li YM.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20228-33. doi: 10.1073/pnas.0910757106. Epub 2009 Nov 11.


A miniaturized 1536-well format gamma-secretase assay.

Shelton CC, Tian Y, Shum D, Radu C, Djaballah H, Li YM.

Assay Drug Dev Technol. 2009 Oct;7(5):461-70. doi: 10.1089/adt.2009.0202.


An exo-cell assay for examining real-time gamma-secretase activity and inhibition.

Shelton CC, Tian Y, Frattini MG, Li YM.

Mol Neurodegener. 2009 Jun 2;4:22. doi: 10.1186/1750-1326-4-22.


gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK.

Cancer Res. 2009 Jan 15;69(2):573-82. doi: 10.1158/0008-5472.CAN-08-2088.


Stereo-controlled synthesis of novel photoreactive gamma-secretase inhibitors.

Yang G, Yin YI, Chun J, Shelton CC, Ouerfelli O, Li YM.

Bioorg Med Chem Lett. 2009 Feb 1;19(3):922-5. doi: 10.1016/j.bmcl.2008.11.117. Epub 2008 Dec 7.


Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH.

Eur J Pharmacol. 2007 Feb 14;557(1):44-8. Epub 2006 Nov 10.


Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling.

DeYulia GJ Jr, Cárcamo JM, Bórquez-Ojeda O, Shelton CC, Golde DW.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5044-9. Epub 2005 Mar 28.


Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.

Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, Cravatt BF.

J Pharmacol Exp Ther. 2004 Nov;311(2):441-8. Epub 2004 Jun 30.


Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.

Lichtman AH, Shelton CC, Advani T, Cravatt BF.

Pain. 2004 Jun;109(3):319-27.


Supplemental Content

Loading ...
Support Center